Hims vs Strut Health: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Strut Health beats Hims overall, scoring 8.2/10 vs 7.9/10. Strut Health is more affordable at $149/mo vs $199/mo. Choose Hims for men who want a well-known publicly-traded brand and fda-appr. Choose Strut Health for users who prefer a needle-free oral semaglutide option at a .
A side-by-side look at Hims and Strut Health to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hims
#9 of 52The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy (injection and pill) and Ozempic through a direct Novo Nordisk partnership, alongside their existing compounded semaglutide program. Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.
Visit HimsStrut Health
#5 of 52Oral-focused GLP-1 provider offering needle-free semaglutide options for users who prefer pills over injections.
Visit Strut Health| Feature | Hims | Strut Health |
|---|---|---|
| Our Score | 7.9/10 | 8.2/10 |
| Starting Price | $199/mo | $149/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors | Users who prefer a needle-free oral semaglutide option at a reasonable price |
| Ranking | #9 | #5 |
| Get started | Visit Hims | Visit Strut Health |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +$199/mo all-inclusive for compounded semaglutide, including consultations and shipping.
- +Polished app and web experience, among the best user interfaces in men's telehealth.
- +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.
Cons
- −Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Easy to confuse with their compounded semaglutide. Read the product page carefully before signing up.
- −Brand Wegovy at $599/mo is not competitive with LillyDirect/NovoCare cash prices or with Hers ($149/mo for the same product via the same Novo partnership).
- −Generic high-volume support, large patient base means less personalized attention than smaller competitors.
Strut Health
Pros
- +Specializes in oral compounded semaglutide, the go-to for patients who absolutely won't do injections
- +Needle-free oral semaglutide tablets from $99/mo, one of the lowest oral entry prices in the table, with oral tirzepatide ($199/mo) and auto-refill injectables ($149–$199/mo) if you switch formats
- +Clear educational content about oral semaglutide absorption and how to maximize effectiveness
- +Simple enrollment: online questionnaire, async provider review, medication shipped to your door
Cons
- −Compounded only, no brand-name Wegovy or Zepbound. Oral tablets carry a bioavailability caveat vs injections, so results may come slower on the needle-free formats.
- −Oral compounded semaglutide has lower bioavailability than injectable forms, so plan for potentially slower or smaller weight-loss results
Our Verdict
Strut Health edges out Hims with a score of 8.2/10 vs 7.9/10. If budget is your priority, Strut Health starts at $149/mo compared to Hims's $199/mo. Hims offers both brand-name and compounded medications, giving you more flexibility. Choose Hims if you want: men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose Strut Health if you want: users who prefer a needle-free oral semaglutide option at a reasonable price.
Still undecided? Editor's Featured Pick
Yucca Health
$146/mo · 7.7/10 · Compounded
If neither Hims nor Strut Health feels like the right fit, our featured pick across all 52 GLP-1 telehealth providers is Yucca Health. It is not the highest-scored provider in our full rankings. We feature it for its low-friction value: a flat $146/mo that stays the same at every dose.
Read Full Reviews
Related comparisons
Other matchups readers comparing Hims or Strut Health tend to look at next.
- Hims vs MEDVi$179/mo
- Hims vs Hers$199/mo
- Hims vs Shed$199/mo
- Strut Health vs TrimRx$149/mo
- Strut Health vs Maximus$150/mo
- Strut Health vs Embody$149/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.